Aqr Capital Management LLC Cytom X Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $599,545 - $1.13 Million	391,860 New	391,860 $717,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $67,670 - $129,221	-17,486 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $504,571 - $751,017	-116,799 Reduced 86.98%	17,486 $89,000
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $210,643 - $329,775	33,277 Added 32.94%	134,285 $850,000
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $151,278 - $206,289	-22,921 Reduced 18.5%	101,008 $781,000
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $12,532 - $15,302	1,937 Added 1.59%	123,929 $812,000
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $447,581 - $603,380	-68,333 Reduced 35.9%	121,992 $811,000
Q2 2020 Aug 17, 2020	BUY	$7.4 - $14.64 $369,896 - $731,795	49,986 Added 35.62%	190,325 $1.59 Million
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $31,699 - $75,516	8,781 Added 6.67%	140,339 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $397,573 - $685,179	76,900 Added 140.69%	131,558 $1.09 Million
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $119,563 - $198,462	16,201 Added 42.13%	54,658 $403,000
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $152,928 - $186,621	16,356 Added 74.01%	38,457 $431,000
Q1 2019 May 14, 2019	BUY	$9.5 - $19.16 $33,079 - $66,715	3,482 Added 18.7%	22,101 $238,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $176,022 - $258,139	-13,871 Reduced 42.69%	18,619 $281,000
Q3 2018 Nov 15, 2018	SELL	$18.04 - $26.41 $157,362 - $230,374	-8,723 Reduced 21.17%	32,490 $601,000
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $96,188 - $133,530	-4,499 Reduced 9.84%	41,213 $942,000
Q1 2018 May 15, 2018	SELL	$21.76 - $34.22 $1.08 Million - $1.7 Million	-49,675 Reduced 52.08%	45,712 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $812,269 - $987,120	42,751 Added 81.22%	95,387 $2.01 Million
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $712,165 - $956,396	52,636	52,636 $956,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

49.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.56 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.39 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.34 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.04 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.6 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account